Mumbai, Nov. 20 -- Marksans Pharma announced that its wholly owned subsidiary Relonchem in UK has received Marketing Authorization for its product Cetirizine Dihydrochloride 1 mg/ml Oral Solution from UK MHRA.

Published by HT Digital Content Services with permission from Capital Market....